Ionis: Potentially A Great Time To Buy Ahead Of Q1 Earnings (Upgrade)

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.It's been around six months since I last updated on Ionis Pharmaceuticals (NASDAQ: IONS ), the Carlsbad, California-based developer of antisense, oligonucleotide therapeuti ...